Mohamed Abdoh Rafai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohamed Abdoh Rafai has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Hicham El Otmani
Neurology Department, Ibn Rochd University Hospital Center, Casablanca, Morocco
5 shared publications - Bouchra El Moutawakil
Hassan II University of Casablanca, Faculty of Medicine and Pharmacy of Casablanca, Rue Tarik Ibn Ziad, Casablanca, 20100, Morocco; Department of Neurology, CHU Ibn Rochd, Casablanca, Morocco; Laboratory of Genetics and Molecular Pathology, Faculty of Medicine and Pharmacy, Casablanca, Morocco
4 shared publications - Kamal Haddouali
Hassan II University of Casablanca, Faculty of Medicine and Pharmacy of Casablanca, Rue Tarik Ibn Ziad, Casablanca, 20100, Morocco; Department of Neurology, CHU Ibn Rochd, Casablanca, Morocco
4 shared publications - Salma Bellakhdar
Hassan II University of Casablanca, Faculty of Medicine and Pharmacy of Casablanca, Rue Tarik Ibn Ziad, Casablanca, 20100, Morocco; Department of Neurology, CHU Ibn Rochd, Casablanca, Morocco; Laboratory of Genetics and Molecular Pathology, Faculty of Medicine and Pharmacy, Casablanca, Morocco
4 shared publications - Asmae Sikkal
Hassan II University of Casablanca, Faculty of Medicine and Pharmacy of Casablanca, Rue Tarik Ibn Ziad, Casablanca, 20100, Morocco; Department of Neurology, CHU Ibn Rochd, Casablanca, Morocco
3 shared publications - Hajar Khattab
Hassan II University of Casablanca, Faculty of Medicine and Pharmacy of Casablanca, Rue Tarik Ibn Ziad, Casablanca, 20100, Morocco; Department of Neurology, CHU Ibn Rochd, Casablanca, Morocco
3 shared publications
Latest Publications
- 22 June 2026
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 112, 107337
Economic and social burden of multiple sclerosis in Morocco: a tertiary care center study
- 22 June 2026
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 112, 107337
Economic and social burden of multiple sclerosis in Morocco: a tertiary care center study
- Open Access
- 23 March 2026
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2026 (3) , omag016
Paroxysmal motor signs in multiple sclerosis: an illustrative videotaped case
Multiple sclerosis (MS) presents with a wide spectrum of neurological manifestations, among which paroxysmal motor phenomena remain a diagnostic and therapeutic challenge. We report the case of a 29-year-old male diagnosed with relapsing–remitting MS (RRMS) who exhibited episodes of paroxysmal dystonia, dysarthria-ataxia, and ptosis. Brain MRI revealed multiple demyelinating plaques, including a contrast-enhancing lesion in the right midbrain, which provides an anatomical correlation with the patient's neurological manifestation. The dystonic movements resolved with corticosteroid therapy, while symptomatic management with carbamazepine was required for dysarthria-ataxia. Ocrelizumab has been proposed as a long-term disease-modifying treatment. This case highlights the importance of recognizing paroxysmal motor signs in MS for early diagnosis and tailored management, despite their elusive pathogenesis.
- 23 March 2026
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2026 (3) , omag016
Open AccessParoxysmal motor signs in multiple sclerosis: an illustrative videotaped case
Multiple sclerosis (MS) presents with a wide spectrum of neurological manifestations, among which paroxysmal motor phenomena remain a diagnostic and therapeutic challenge. We report the case of a 29-year-old male diagnosed with relapsing–remitting MS (RRMS) who exhibited episodes of paroxysmal dystonia, dysarthria-ataxia, and ptosis. Brain MRI revealed multiple demyelinating plaques, including a contrast-enhancing lesion in the right midbrain, which provides an anatomical correlation with the patient's neurological manifestation. The dystonic movements resolved with corticosteroid therapy, while symptomatic management with carbamazepine was required for dysarthria-ataxia. Ocrelizumab has been proposed as a long-term disease-modifying treatment. This case highlights the importance of recognizing paroxysmal motor signs in MS for early diagnosis and tailored management, despite their elusive pathogenesis.
- Open Access
- 24 December 2025
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2025 (12)
Paraneoplastic progressive Supranuclear palsy: a case report and literature review
Progressive supranuclear palsy-Richardson syndrome (PSP-RS) is a sporadic atypical parkinsonian disorder typically resistant to levodopa. While most cases are neurodegenerative, various conditions (genetic, vascular, infectious, or paraneoplastic) can mimic this phenotype, termed PSP-like or PSP mimics. Although paraneoplastic PSP is extremely rare, it is important to recognize because of its potential reversibility. The diagnosis can be particularly challenging, especially when classical tumor markers or imaging fail to identify a clear neoplastic origin. Here, we describe a 39-year-old man with an Anti-Ri–mediated PSP-like syndrome in whom an extensive evaluation, including surgical removal of two suspicious sites (thymus and testis), failed to identify an underlying tumor. The patient presented with rapidly progressive symptoms characteristic of PSP-RS, raising clinical suspicion for a paraneoplastic cause. We also review the literature on paraneoplastic PSP.
- 24 December 2025
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2025 (12)
Open AccessParaneoplastic progressive Supranuclear palsy: a case report and literature review
Progressive supranuclear palsy-Richardson syndrome (PSP-RS) is a sporadic atypical parkinsonian disorder typically resistant to levodopa. While most cases are neurodegenerative, various conditions (genetic, vascular, infectious, or paraneoplastic) can mimic this phenotype, termed PSP-like or PSP mimics. Although paraneoplastic PSP is extremely rare, it is important to recognize because of its potential reversibility. The diagnosis can be particularly challenging, especially when classical tumor markers or imaging fail to identify a clear neoplastic origin. Here, we describe a 39-year-old man with an Anti-Ri–mediated PSP-like syndrome in whom an extensive evaluation, including surgical removal of two suspicious sites (thymus and testis), failed to identify an underlying tumor. The patient presented with rapidly progressive symptoms characteristic of PSP-RS, raising clinical suspicion for a paraneoplastic cause. We also review the literature on paraneoplastic PSP.
- Open Access
- 1 September 2025
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 16 (5) , 941-948
Subthalamic Nucleus Deep Brain Stimulation in Early-onset Parkinson’s Disease: Clinical Outcomes in LRRK2 Mutation Carriers Compared to Non-Carriers
Introduction: Subthalamic nucleus deep brain stimulation (STN-DBS) is an established treatment for early-onset Parkinson’s disease (EOPD). While the effect of STN-DBS on patients with LRRK2 G2019S mutation has been largely investigated, data specific to EOPD patients with this mutation remain scarce. This study examines the impact of the LRRK2 G2019S ...
- 1 September 2025
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 16 (5) , 941-948
Open AccessSubthalamic Nucleus Deep Brain Stimulation in Early-onset Parkinson’s Disease: Clinical Outcomes in LRRK2 Mutation Carriers Compared to Non-Carriers
Introduction: Subthalamic nucleus deep brain stimulation (STN-DBS) is an established treatment for early-onset Parkinson’s disease (EOPD). While the effect of STN-DBS on patients with LRRK2 G2019S mutation has been largely investigated, data specific to EOPD patients with this mutation remain scarce. This study examines the impact of the LRRK2 G2019S ...
- Open Access
- 31 May 2023
- Published by Université Paris Cité in Emerging Neurologist
- Vol. 2 (1) , 10-12
Reversible splenial lesion of the corpus callosum secondary to severe intracranial hypertension in children: a case report
Introduction. Reversible lesions in the splenium of the corpus callosum are a recognized radio-clinical entity, which is rarely associated with idiopathic intracranial hypertension, especially in children. We present a case. Case report. We describe the case of an 11-year-old prepubescent female patient with no significant medical history. She presented with idiopathic intracranial hypertension syndrome and exhibited a nodular lesion in the splenium of the corpus callosum on the MRI scan. Initial medical treatment with acetazolamide and a subtractive lumbar puncture failed to improve the patient's condition. Consequently, an emergency ventriculoperitoneal shunt procedure was performed, resulting in a favorable clinical outcome. A follow-up MRI was conducted six months later, revealing normalization of the imaging results. Conclusion. Further studies are needed to understand the pathophysiology of reversible lesions in the splenium of the corpus callosum during idiopathic intracranial hypertension.
- 31 May 2023
- Published by Université Paris Cité in Emerging Neurologist
- Vol. 2 (1) , 10-12
Open AccessReversible splenial lesion of the corpus callosum secondary to severe intracranial hypertension in children: a case report
Introduction. Reversible lesions in the splenium of the corpus callosum are a recognized radio-clinical entity, which is rarely associated with idiopathic intracranial hypertension, especially in children. We present a case. Case report. We describe the case of an 11-year-old prepubescent female patient with no significant medical history. She presented with idiopathic intracranial hypertension syndrome and exhibited a nodular lesion in the splenium of the corpus callosum on the MRI scan. Initial medical treatment with acetazolamide and a subtractive lumbar puncture failed to improve the patient's condition. Consequently, an emergency ventriculoperitoneal shunt procedure was performed, resulting in a favorable clinical outcome. A follow-up MRI was conducted six months later, revealing normalization of the imaging results. Conclusion. Further studies are needed to understand the pathophysiology of reversible lesions in the splenium of the corpus callosum during idiopathic intracranial hypertension.